Risk of PPI use higher after LSG vs. LRYGB
Browse by category
AI analysis finds huge public interest in GLP-1 drugs for weight loss and mental health benefits
Patients receiving tirzepatide were significantly more likely to achieve clinically meaningful weight loss compared with those treated receiving semaglutide
Most Americans do not use GLP-1s long enough to see meaningful weight-loss
US Task Force recommends intensive, comprehensive behavioural interventions for children and teens with a high BMI
ARMMS-T2D study alliance continues to show benefits of MBS over medical interventions for those with T2DM
Bariatric surgery cuts risk of heart complications and death in patients with obstructive sleep apnoea and obesity
BMS associated with lower all-cause mortality compared with GLP-1RA treatment
Experts issue nutritional recommendations for patients treated with anti-obesity medications
ASGARD Trial: BPD-DS may not be a better surgical strategy than RYGB for patients with a BMI 50-60